Hybio Pharmaceutical Co., Ltd. (300199.SZ) SHZ

18.41

+0.06(+0.33%)

Updated at December 05 12:40PM

Currency In CNY

Valuation

Market Cap11.19B
Enterprise Value12.6B
P/E Ratio-240.12
PEG Ratio0.78
Price/Sales Ratio18.05
Price/Book Ratio24.97
Enterprise/Revenue20.04
Enterprise/EBITDA83.29

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.08
Operating Margin-0.02

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.1

Income Statement

Revenue590.2M
Revenue/Share1.02
Gross Profit308.73M
EBITDA113.52M
Net Income-173.65M
Diluted EPS-0.2

Balance Sheet

Total Cash140.42M
Total Cash/Share0.16
Total Debt1.93B
Total Debt/Equity2.97
Current Ratio0.37
Book Value Per Share0.75

Price History

52-Week Change43.47
52-Week High31.19
52-Week Low10.5
Moving Average 50 Days20.48
Moving Average 200 Days18.5

Statistics

Average Volume46.42M
Shares Outstanding883.24M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-1.13
Last Split Factor2:1
Last Split DateApril 14, 2015